
Nigeria’s RxAll and Sproxil among 7 African healthtechs selected for i3’s third cohort
Two Nigerian healthtech startups, RxAll and Sproxil, are among seven growth-stage companies selected for the third cohort of Investing in Innovation Africa (i3). i3 is a pan-African initiative aimed at scaling innovative healthcare solutions across the …